Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study

Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study

Background: Neutralizing antibodies targeting the SARS-CoV-2 Spike protein reduce COVID-19-related risk of hospitalization, particularly in high-risk individuals. The COCOPREV-R study aimed to evaluate and compare clinical outcomes in high-risk SARS-CoV-2 patients treated with dual monoclonal antibo...

Full description

Bibliographic Details
Main Authors: Karen Zafilaza, Jonathan Bellet, Aurélie Truffot, Vincent Foulongne, Manuela Mireille Onambele, Maud Salmona, Camille Vellas, Claire Périllaud-Dubois, Audrey Mirand, Elisabeth André-Garnier, Enagnon Kazali Alidjinou, Ségolène Brichler, Honorine Fenaux, Magali Bouvier-Alias, Cédric Hartard, Céline Dorival, Fabrice Carrat, Anne-Geneviève Marcelin, Karl Stefic, Cathia Soulie
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Viruses
Subjects:
COVID-19
SARS-CoV-2
monoclonal antibody therapy
spike gene
immune escape mutation
Online Access:https://www.mdpi.com/1999-4915/16/10/1542

Internet

https://www.mdpi.com/1999-4915/16/10/1542

Similar Items